dc.contributor.author
Mei, Jie
dc.contributor.author
Banneke, Stefanie
dc.contributor.author
Lips, Janet
dc.contributor.author
Kuffner, Melanie T. C.
dc.contributor.author
Hoffmann, Christian J.
dc.contributor.author
Dirnagl, Ulrich
dc.contributor.author
Endres, Matthias
dc.contributor.author
Harms, Christoph
dc.contributor.author
Emmrich, Julius V.
dc.date.accessioned
2019-10-28T10:38:58Z
dc.date.available
2019-10-28T10:38:58Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/25814
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-25575
dc.description.abstract
Ideally, humane endpoints allow for early termination of experiments by minimizing an animal’s discomfort, distress and pain, while ensuring that scientific objectives are reached. Yet, lack of commonly agreed methodology and heterogeneity of cut-off values published in the literature remain a challenge to the accurate determination and application of humane endpoints.
With the aim to synthesize and appraise existing humane endpoint definitions for commonly used physiological parameters, we conducted a systematic review of mouse studies of acute and chronic disease models, which used body weight, temperature and/or sickness scores for endpoint definition. In the second part of the study, we used previously published and unpublished data on weight, temperature and sickness scores from mouse models of sepsis and stroke and applied machine learning algorithms to assess the usefulness of this method for parameter selection and endpoint definition across models. Studies were searched for in two electronic databases (MEDLINE/Pubmed and Embase). Out of 110 retrieved full-text manuscripts, 34 studies were included. We found large intra- and inter-model variance in humane endpoint determination and application due to varying animal models, lack of standardized experimental protocols and heterogeneity of performance metrics (part 1).
Machine learning models trained with physiological data and sickness severity score or modified DeSimoni neuroscore identified animals with a high risk of death at an early time point in both mouse models of stroke (male: 93.2% at 72h post-treatment; female: 93.0% at 48h post-treatment) and sepsis (96.2% at 24h post-treatment), thus demonstrating generalizability in endpoint determination across models (part 2).
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
animal use alternatives
en
dc.subject
animal welfare
en
dc.subject
animal experimentation
en
dc.subject
refinement and replacement
en
dc.subject
middle cerebral artery stroke
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Refining Humane Endpoints in Mouse Models of Disease by Systematic Review and Machine Learning-Based Endpoint Definition
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.doi
10.14573/altex.1812231
dcterms.bibliographicCitation.journaltitle
ALTEX: Alternatives to Animal Experimentation
dcterms.bibliographicCitation.number
4
dcterms.bibliographicCitation.originalpublishername
Springer Spektrum
dcterms.bibliographicCitation.volume
36
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
31026040
dcterms.isPartOf.eissn
1868-596X